Narrow search
Showing 1 - 10 of 252
Cover Image
Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
Carron, Christine; Voirol, Pierre; Eggimann, Philippe; … - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 355-358
Persistent link: https://www.econbiz.de/10011005058
Cover Image
PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites: A NICE Medical Technology Guidance
White, Judith; Carolan-Rees, Grace - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 299-308
The PleurX peritoneal drainage catheter for drainage of malignant ascites in a community setting has been evaluated by the NICE Medical Technologies Evaluation Programme. This article outlines the evidence included in the Sponsor's submission, the independent critique by the External Assessment...
Persistent link: https://www.econbiz.de/10011005059
Cover Image
Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach
Baumler, Michael Bumler; Stargardt, Tom; Schreyogg, … - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 235-248
Background:Background: The high number of patients with acute myocardial infarction (AMI) has facilitated greater research, resulting in the development of innovative medical devices. So far, results from economic evaluations that compared drug-eluting stents (DES) and bare-metal stents (BMS)...
Persistent link: https://www.econbiz.de/10011005060
Cover Image
Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
Roman, Antonio; Barberà, Joan A. Barber; Escribano, Pilar - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 175-188
health states corresponding with the NYHA classes plus death were allowed for patients in the model. Changing the treatment … transition between health states on a 12-week cycle basis. The study perspective was that of the National Health System (NHS …-Salud Database in 2009 and are given in euros (&U20AC;). Data on health resources and treatment pathways were informed by a four …
Persistent link: https://www.econbiz.de/10011005061
Cover Image
An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of Côte d'Ivoire
Diaby, Vakaramoko; Lachaine, Jean - In: Applied Health Economics and Health Policy 9 (2011) 6, pp. 389-402
; Mutuelle Générale des Fonctionnaires et Agents de l'État de Côte d'Ivoire) is a health mutual fund providing coverage (medical … (cost per patient). This selection would start from the first treatment, going down the list until the $US66 per …
Persistent link: https://www.econbiz.de/10011005062
Cover Image
Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
Slof, John - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 201-215
evaluation was conducted from the perspectives of French society and the French public health system based on patient-level data … point of view. In terms of drug costs only, however, non-early treatment is less expensive. From the public health system … public health system point of view. …
Persistent link: https://www.econbiz.de/10011005063
Cover Image
The Chinese Healthcare System: Structure, Problems and Challenges
Hougaard, Jens Leth.; Østerdal, Lars Peter. sterdal; Yu, Yi - In: Applied Health Economics and Health Policy 9 (2011) 1, pp. 1-13
We describe the structure and present situation of the Chinese healthcare system and discuss its primary problems and challenges. We discuss problems with inefficient burden sharing, adverse provider incentives and huge inequities, and seek explanations in the structural features of the Chinese...
Persistent link: https://www.econbiz.de/10011005064
Cover Image
Insensitivity to Scope in Contingent Valuation Studies: Reason for Dismissal of Valuations?
Søgaard, Rikke Sgaard; Lindholt, Jes; Gyrd-Hansen, Dorte - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 397-405
Background:Background: The credibility of contingent valuation studies has been questioned because of the potential occurrence of scope insensitivity, i.e. that respondents do not react to higher quantities or qualities of a good. Abstract: Objective:Objective: The aim of this study was to...
Persistent link: https://www.econbiz.de/10011005065
Cover Image
Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
Dilla, Tatiana; Valladares, Amparo; Nicolay, Claudia; … - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 417-430
Background:Background: Weight management is considered a key therapeutic strategy in type 2 diabetes mellitus. However, little is known about the impact of weight loss or body mass index (BMI) reduction on type 2 diabetes-related healthcare costs. Abstract: Objective:Objective: The aim of this...
Persistent link: https://www.econbiz.de/10011005066
Cover Image
What Explains Willingness to Pay for Smoking-Cessation Treatments - Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
Olsen, Jan Abel.; Røgeberg, Ole J. Rgeberg; Stavem, Knut - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 407-415
method to provide valid and reliable answers that reflect true preferences for health and healthcare. …
Persistent link: https://www.econbiz.de/10011005067